|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.140 SEK | -1.89% |
|
-10.09% | +23.38% |
| 05-22 | Intervacc AB Completes Successful Evaluation of Us Strain of Strangles Pathogen Ahead of Clinical Trials | CI |
| 05-15 | Sweden's Intervacc Elects New Chair | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTERVACC AB | Bio Therapeutic Drugs | -1.89% | -10.09% | +23.38% | +15.15% | -98.50% | 40.88M |  |  | |
- Stock Market
- Stocks
- IVACC Stock
- Charts Intervacc AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
